Jump to:
loading...| Preferred Name | erenumab | |
| Synonyms |
AMG 334 fremanezumab-vfrm galcanezumab-gnlm Ajovy Aimovig erenumab-aooe Emgality |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C000605816 |
|
| altLabel |
AMG 334 fremanezumab-vfrm galcanezumab-gnlm Ajovy Aimovig erenumab-aooe Emgality |
|
| cui |
C4731566 C4548861 C4731561 C4692289 C4723543 C4723538 C4542165 C4692294 |
|
| HM |
D061067 |
|
| Inverse of RB |
I5I8VB78VT |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
20160313 |
|
| MeSH Frequency |
248 |
|
| MMR |
20190130 |
|
| notation |
C000605816 |
|
| PA |
D000077221 |
|
| prefLabel |
erenumab |
|
| SC |
1 |
|
| Scope Statement |
anti-human calcitonin gene-related peptide monoclonal antibody for the prevention of migraine headaches |
|
| SRC |
Pharmacol Exp Ther. 2016 Jan;356(1):223-31. |
|
| TERMUI |
T000951039 T000947043 T000938188 T000951041 T000897061 T000951038 T000951042 T000947042 |
|
| TH |
NLM (2016) FDA SRS (2017) NLM (2019) USAN (19XX) INN (19XX) NLM (2017) |
|
| tui |
T109 T116 T129 T121 |
Create mapping